Join us for an exciting conference on the developing role of precision healthcare to improve health outcomes for people living with cancer and rare diseases, or at risk of developing cancer.
Learn about the latest collaborations and approaches, how organisations, systems and bioinformatics can help healthcare professionals match patients to the right therapies and clinical trials, and how these developments are ushering in a new era of personalised treatment strategies.
SESSION 1: PRECISION HEALTHCARE – THE WHAT, WHO AND HOWThe opening session will address the precision medicine landscape and explore topics such as cellular immunotherapy, precision oncology and pharmacogenomics. Discover how access to genomics technologies can revolutionise drug development by reducing risks and costs, and improving approval rates. Learn about the latest advances in high-throughput, clinically actionable multi-gene sequencing. Explore the roles that intellectual property, capital raising and partnering play in progressing research findings to the clinic.SESSION 2: MAKING IT HAPPEN – IDENTIFYING, DETECTING AND ASSESSING CANCER RISKThis session will showcase the latest advancements to identify, detect and assess cancer risk. Our speakers will highlight collaborations that are driving innovation in the field and the importance of proteomics, bioinformatics and enabling infrastructure platforms established under TAGC (The Advanced Genomics Collaboration) and Cancer Liquid Biopsy project. They will also explore patient advocacy and the digital ecosystem.SESSION 3: RESEARCH AND RISK ASSESSMENT – HEART DISEASE, DIABETES, NEURODEGENERATION AND VISION LOSSThis session will explore personalised, point-of-care preventative risk tests for heart disease, diabetes and cancer. And exciting research using cell and gene therapies to tackle vision loss, stroke, brain injury and neurodegenerative diseases. We will also address the enablers behind precision cardiology.SESSION 4: CONNECTORS AND ENABLERS – WHAT YOU NEED TO KNOWThe final session will discuss integrating precision medicine approaches such as biobanking, digital health-enabled genomics and collaborative efforts into mainstream healthcare. We will also explore the potential in Australian research, access to next-generation treatments, molecular screening and biomarker-led clinical trials, ethics and genetic counselling.
Date: Wednesday 4 October 2023
8:15 am – 8:45am: Guest arrival and registration
8:45am – 5:30pm: Sessions 1 – 4
5:30pm – 6:30pm: Networking
Venue: Monash College, Level 2 Auditorium, 750 Collins Street, Docklands, VIC 3008
Host: Jeff Malone, CEO, BioMelbourne Network
In-person: Member $440; Non Member $800; Student / Researcher $150
Online: Member $60; Non Member $140; Student / Researcher $25
A full refund can be issued up to 14 days prior to the event.
No refunds can be issued within 14 days of the event.
A full refund can be issued up to 7 days prior to the event.
No refunds can be issued within 7 days of the event.
In the event of postponement by BioMelbourne Network, all registrations will be carried forward to a new date. Should the program be cancelled, or you are unable to attend on the rescheduled date, a full refund will be made available.
Please be advised that this event will be recorded and photographs will be taken which may be used by BioMelbourne Network in future marketing materials. Please notify us if you do not consent to us recording or photographing you and using your image and likeness as mentioned.